Clinical trial
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced…
NCT00036517 · PhytoCeutica, Industry · Terminated
Key facts
| NCT number | NCT00036517 |
|---|---|
| Title | Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer |
| Official title | A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer |
| Lead sponsor | PhytoCeutica, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Diarrhea |
| Intervention type | Drug |
| Interventions | PHY906 |
| Enrollment | 30 |
| Start date | Feb 1, 2002 |
| Completion | Mar 1, 2003 |
| First posted | May 13, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: